Intuitive Surgical, Inc. (ISRG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2023. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be release ...

Investors are always looking for stocks that are poised to beat at earnings season and Intuitive Surgical, Inc. (ISRG) , may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Intuitive Surgical is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — ...

Despite ongoing concerns about a rich valuation, shares of healthcare robotics and artificial intelligence (AI) stock Intuitive Surgical (ISRG 0.39%) had a stellar 2023. In fact, management just provided preliminary fourth-quarter 2023 earnings, as well as a first look at expectations for 2024, and investors were pleased. Intuitive stock just hit fresh all-time highs, and rallied nearly 40% over the last 12-month stretch. The company believes it has ample opportunities left to address critical issues in hea ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Intuitive Surgical, Inc. (ISRG) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 5.56%.For the most recent quarter, Intuitive Surgic ...

Core Insights - Intuitive Surgical (ISRG) reported strong preliminary revenue results for Q4 2023, with net sales estimated at least $1.93 billion, reflecting a 17% year-over-year increase [1] - The company anticipates full-year revenues of $7.12 billion for 2023, indicating a 14% year-over-year growth [2] Revenue Performance - Q4 2023 net sales are projected at $1.93 billion, surpassing the Zacks Consensus Estimate of $1.86 billion [1] - Sales from instruments and accessories reached $1.14 billion, marking a 22% year-over-year growth, driven by increased da Vinci procedure volume and higher pricing [1] - Full-year revenues from instruments and accessories were $4.28 billion, up 22%, while systems revenue remained flat at $1.68 billion [2] Procedure Volume and System Placements - Da Vinci procedures grew approximately 21% worldwide in Q4 2023, benefiting from a favorable comparison to the previous year when COVID-19 impacted volumes [2] - The company placed 415 da Vinci systems in Q4 2023, reflecting a 12% year-over-year increase, which is expected to support continued growth in procedure volumes in 2024 [2][3] Market Recovery - The company completed about 2,286,000 surgical procedures with da Vinci systems in 2023, a 22% increase from 2022, attributed to improved market conditions, particularly in general surgery and cancer procedures [3] - COVID-19 disruptions were minimal in the second half of 2023, leading to a recovery in procedure volumes, particularly in China [4] Stock Performance - ISRG shares rose 15.4% from October 1 to December 31, 2023, outperforming the industry growth of 10.1% and the S&P 500's 10.6% increase during the same period [5]

Another healthy day for market indices today is always a welcome sight. We’re operating with little data to this stage in the week, but we won’t turn our nose up at modest bullish sentiment. The Dow was just off session highs, +170 points, +0.45%, while the S&P 500 moved back above 4780: +0.57%. Both are a smidge off all-time highs reached just last week. The Nasdaq outperformed the field, +111 points, +0.75% and riding a four-day winning streak, while the small-cap Russell 2000 took a breather today, -0.24 ...

Key TakeawaysThe S&P 500 gained 0.6% on Wednesday, Jan. 10, 2024, ahead of inflation data and bank earnings later in the week.Intuitive Surgical shares surged after it beat revenue estimates on increased usage of its da Vinci robotic surgical system.Capital One Financial fell after a BMO downgrade on concerns over charge-offs for uncollected debt.The S&P 500 posted a gain of 0.6% on Wednesday ahead of key inflation data and bank earnings due later in the week. The Nasdaq rose 0.8%, while the Dow moved highe ...

Summary of Intuitive Surgical, Inc. Conference Call Company Overview - **Company**: Intuitive Surgical, Inc. (NASDAQ: ISRG) - **Event**: JPMorgan Healthcare Conference Call - **Date**: January 10, 2024 Key Points Industry and Market Dynamics - The company focuses on minimally invasive care and acute interventions, emphasizing the need for advanced technologies to improve healthcare outcomes [2][3] - The total experience on da Vinci platforms has surpassed 14 million procedures, with over 2.2 million procedures performed in the last year [3][4] - The installed base of systems has grown to over 9,100, with significant placements across various platforms [4] Financial Performance - The company reported a 22% growth in procedures for the year, with a projected growth rate of 13% to 16% for 2024 [10][46] - Revenue growth is slower than procedure growth due to a higher mix of risk-sharing arrangements and leasing in the capital portfolio [12][13] - The installed base grew by 14%, indicating increased utilization of systems [11] Challenges and Risks - Environmental uncertainties in China, including regulatory pressures and pricing regulations, have impacted business performance [5] - The rise of GLP-1 medications has led to a deceleration in bariatric surgery growth, which is expected to continue [6][48] - Manufacturing constraints, particularly in the flexible bronchoscopy space, have limited system installations [7][8] Growth Opportunities - The company sees a potential market of approximately 7 million patients annually, with aspirations to grow this to 21 million through innovation [14][15] - The Ion system for flexible bronchoscopy is gaining traction, with significant growth in procedures [16][17] - The company is focused on expanding its platforms and indications, particularly in international markets [39] Technological Advancements - Intuitive Surgical is investing in AI and machine learning to enhance surgical outcomes and operational efficiency [24][26] - The company is developing tools for preoperative planning, intraoperative guidance, and postoperative analytics [28][30] - The integration of telemedicine and teleproctoring capabilities is being explored to enhance surgical support [33] Customer Engagement and Satisfaction - The company measures customer satisfaction through Net Promoter Scores, achieving an 80% score in the U.S. [38] - The focus is on aligning with customer needs and demonstrating the value of their products through data-driven outcomes [61][62] Future Outlook - The company plans to focus on innovation, quality improvement, and optimizing manufacturing processes in 2024 [39][55] - There is an emphasis on understanding the impact of AI and big data on the surgical robotics field over the next decade [64] Additional Insights - The company is cautious about the impact of economic conditions on procedure growth, particularly in relation to patient backlogs and market dynamics in China [47][48] - The competitive landscape is influenced by disease state-level competition, with a focus on delivering better patient outcomes and experiences [60][61] This summary encapsulates the key insights from the conference call, highlighting the company's performance, challenges, growth opportunities, and strategic focus areas for the future.

Intuitive Surgical, Inc. (NASDAQ:ISRG) JPMorgan Healthcare Conference Call January 10, 2024 12:00 PM ET Company Participants Gary Guthart - CEO & Director Brian King - Head, IR Jamie Samath - SVP & CFO Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Robert Marcus Good morning, everyone. Happy to continue day 3 of the JPMorgan Healthcare Conference. I'm Robbie Marcus, the Medtech Analyst. Really pleased to introduce our next session. CEO of Intuitive Surgical, Gary Guthart, will do a quick ...

Shares of Intuitive Surgical Inc. rallied 9.5% Wednesday to lead S&P 500 gainers, after the maker of robotic surgical equipment updated guidance for fourth-quarter sales with some bullish numbers, buoyed by a recovery in China. The stock ISRG, +10.16% was on track for its biggest one-day gain since April 19, 2023, when it rose 10.9%, and has gained for four of the last five days.The company said late Tuesday it expects fourth-quarter revenue of around $1.93 billion, up 17% and above FactSet forecasts for $1 ...